These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 6405080)

  • 21. [Hypo- and hyperalphalipoproteinemia and genetic abnormalties in reverse cholesterol transport system].
    Matsuyama A; Yamashita S
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():539-44. PubMed ID: 11351645
    [No Abstract]   [Full Text] [Related]  

  • 22. Apolipoprotein defects.
    Breslow JL
    Hosp Pract (Off Ed); 1985 Dec; 20(12):43-9. PubMed ID: 3934198
    [No Abstract]   [Full Text] [Related]  

  • 23. Tangier disease: heterozygote detection and linkage analysis.
    Suarez BK; Schonfeld G; Sparkes RS
    Hum Genet; 1982; 60(2):150-6. PubMed ID: 6951800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotype study of apolipoprotein E isoforms in hyperlipoproteinaemic patients.
    Ghiselli G; Gregg RE; Zech LA; Schaefer EJ; Brewer HB
    Lancet; 1982 Aug; 2(8295):405-7. PubMed ID: 6124804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma.
    Edelstein C; Gordon JI; Vergani CA; Catapano AL; Pietrini V; Scanu AM
    J Clin Invest; 1984 Sep; 74(3):1098-103. PubMed ID: 6432845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial high-density lipoprotein deficiency (Tangier disease): the third Italian case.
    Bracco G; Dotti G; Levis F; David E; Saracco G; Rizzetto M; Verme G
    J Inherit Metab Dis; 1988; 11 Suppl 2():155-7. PubMed ID: 3141697
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical features of lipoprotein disorders.
    Lloyd JK
    Ric Clin Lab; 1982; 12(1):97-100. PubMed ID: 7089428
    [No Abstract]   [Full Text] [Related]  

  • 28. Classification of primary dyslipoproteinemias.
    Dargel R
    Exp Pathol; 1985; 27(2):67-78. PubMed ID: 3888651
    [No Abstract]   [Full Text] [Related]  

  • 29. [Phenotype change in hyperlipoproteinemias].
    Meincke H
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(5):236-9. PubMed ID: 4085393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).
    Schaefer EJ; Kay LL; Zech LA; Brewer HB
    J Clin Invest; 1982 Nov; 70(5):934-45. PubMed ID: 7130397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical syndrome and lipid metabolism in hereditary deficiency of apolipoproteins A-I and C-III, variant 1.
    Norum RA; Forte TM; Alaupovic P; Ginsberg HN
    Adv Exp Med Biol; 1986; 201():137-49. PubMed ID: 3099552
    [No Abstract]   [Full Text] [Related]  

  • 33. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
    Schmitz G; Assmann G; Rall SC; Mahley RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
    Wang CS; Alaupovic P; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies to serum lipoproteins: their present and future use in biology and medicine.
    Watt RM; Carhart RL; Gentile TC; Watt TS
    Pharmacol Ther; 1985; 28(1):29-50. PubMed ID: 2414787
    [No Abstract]   [Full Text] [Related]  

  • 36. [Separation of lipoproteins as a function of their apolipoprotein composition. Clinical applications].
    Fruchart JC
    Ann Biol Clin (Paris); 1986; 44(2):116-21. PubMed ID: 3092704
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic lipoprotein abnormalities producing high blood cholesterol.
    Brown WV; Breslow JL
    Heart Dis Stroke; 1992; 1(6):405-7. PubMed ID: 1344140
    [No Abstract]   [Full Text] [Related]  

  • 38. Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).
    Kay LL; Ronan R; Schaefer EJ; Brewer HB
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2485-9. PubMed ID: 6806810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal apoprotein A-I isoprotein composition in patients with Tangier disease.
    Zannis VI; Lees AM; Lees RS; Breslow JL
    J Biol Chem; 1982 May; 257(9):4978-86. PubMed ID: 7068673
    [No Abstract]   [Full Text] [Related]  

  • 40. Corneal opacification and familial disorders affecting plasma high-density lipoprotein.
    Winder AF; Borysiewicz LK
    Birth Defects Orig Artic Ser; 1982; 18(6):433-40. PubMed ID: 7171769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.